Screener
AbCellera Biologics Inc. ABCL Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
| Line item | December 31, 2025 | June 30, 2026 |
|---|---|---|
| Long-term assets: | ||
| Property and equipment, net | 428,003 | 416,677 |
| Intangible assets, net | 38,381 | 36,530 |
| Goodwill | 47,806 | 47,806 |
| Investments in equity accounted investees | 62,580 | 65,229 |
| Other long-term assets | 51,948 | 62,103 |
| Total long-term assets | 628,718 | 628,345 |
| Total assets | $1,356,950 | $1,307,575 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is AbCellera Biologics Inc.'s goodwill?
- AbCellera Biologics Inc. (ABCL) reported goodwill of $47.81M in Q2 2026.
- How has AbCellera Biologics Inc.'s goodwill changed year-over-year?
- AbCellera Biologics Inc.'s goodwill decreased by 0.0% year-over-year, from $47.81M to $47.81M.
- What is the long-term trend for AbCellera Biologics Inc.'s goodwill?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s goodwill has grown at a 8.7% compound annual growth rate (CAGR), from $31.5M to $47.81M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.
Ask your AI about AbCellera Biologics Inc.'s goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude